Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerd Geisslinger

Showing results (381-390 of 441) with videos related to

Pageof 45
Sort By:
Elife|September 30, 2024
Machine learning and biological validation identify sphingolipids as potential mediators of paclitaxel-induced neuropathy in cancer patientsJörn Lötsch, Khayal Gasimli, Sebastian Malkusch, et al.
Journal of Medicinal Chemistry|August 29, 2017
A Dual Modulator of Farnesoid X Receptor and Soluble Epoxide Hydrolase To Counter Nonalcoholic SteatohepatitisJurema Schmidt, Marco Rotter, Tim Weiser, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 16, 2009
Inhibitor kappaB Kinase beta deficiency in primary nociceptive neurons increases TRP channel sensitivityVanessa Bockhart, Cristina Elena Constantin, Annett Häussler, et al.
Brain, Behavior, and Immunity|February 21, 2015
Lack of ceramide synthase 2 suppresses the development of experimental autoimmune encephalomyelitis by impairing the migratory capacity of neutrophilsJulia Barthelmes, Anika Männer de Bazo, Yael Pewzner-Jung, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 4, 2024
SPMs exert anti-inflammatory and pro-resolving effects through positive allosteric modulation of the prostaglandin EP4 receptorMohamad Wessam Alnouri, Kenneth Anthony Roquid, Rémy Bonnavion, et al.
Journal of Clinical Medicine|July 7, 2019
The Lipid Status in Patients with Ulcerative Colitis: Sphingolipids are Disease-Dependent RegulatedSarah Bazarganipour, Johannes Hausmann, Stephanie Oertel, et al.
Frontiers in Aging Neuroscience|May 16, 2022
The Roles of Long-Term Hyperhomocysteinemia and Micronutrient Supplementation in the <i>App</i> Model of Alzheimer's DiseaseHendrik Nieraad, Natasja de Bruin, Olga Arne, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 12, 2018
The structural basis for cancer drug interactions with the catalytic and allosteric sites of SAMHD1Kirsten M Knecht, Olga Buzovetsky, Constanze Schneider, et al.
Plos One|August 10, 2010
Inhibition of the soluble epoxide hydrolase promotes albuminuria in mice with progressive renal diseaseOliver Jung, Felix Jansen, Anja Mieth, et al.
Journal of Medicinal Chemistry|June 8, 2018
Boosting Anti-Inflammatory Potency of Zafirlukast by Designed PolypharmacologySimone Schierle, Cathrin Flauaus, Pascal Heitel, et al.
Pageof 45

Showing results (381-390 of 441) with videos related to

Sort By:
Pageof 45
Elife|September 30, 2024
Machine learning and biological validation identify sphingolipids as potential mediators of paclitaxel-induced neuropathy in cancer patientsJörn Lötsch, Khayal Gasimli, Sebastian Malkusch, et al.
Journal of Medicinal Chemistry|August 29, 2017
A Dual Modulator of Farnesoid X Receptor and Soluble Epoxide Hydrolase To Counter Nonalcoholic SteatohepatitisJurema Schmidt, Marco Rotter, Tim Weiser, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 16, 2009
Inhibitor kappaB Kinase beta deficiency in primary nociceptive neurons increases TRP channel sensitivityVanessa Bockhart, Cristina Elena Constantin, Annett Häussler, et al.
Brain, Behavior, and Immunity|February 21, 2015
Lack of ceramide synthase 2 suppresses the development of experimental autoimmune encephalomyelitis by impairing the migratory capacity of neutrophilsJulia Barthelmes, Anika Männer de Bazo, Yael Pewzner-Jung, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 4, 2024
SPMs exert anti-inflammatory and pro-resolving effects through positive allosteric modulation of the prostaglandin EP4 receptorMohamad Wessam Alnouri, Kenneth Anthony Roquid, Rémy Bonnavion, et al.
Journal of Clinical Medicine|July 7, 2019
The Lipid Status in Patients with Ulcerative Colitis: Sphingolipids are Disease-Dependent RegulatedSarah Bazarganipour, Johannes Hausmann, Stephanie Oertel, et al.
Frontiers in Aging Neuroscience|May 16, 2022
The Roles of Long-Term Hyperhomocysteinemia and Micronutrient Supplementation in the <i>App</i> Model of Alzheimer's DiseaseHendrik Nieraad, Natasja de Bruin, Olga Arne, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 12, 2018
The structural basis for cancer drug interactions with the catalytic and allosteric sites of SAMHD1Kirsten M Knecht, Olga Buzovetsky, Constanze Schneider, et al.
Plos One|August 10, 2010
Inhibition of the soluble epoxide hydrolase promotes albuminuria in mice with progressive renal diseaseOliver Jung, Felix Jansen, Anja Mieth, et al.
Journal of Medicinal Chemistry|June 8, 2018
Boosting Anti-Inflammatory Potency of Zafirlukast by Designed PolypharmacologySimone Schierle, Cathrin Flauaus, Pascal Heitel, et al.
Pageof 45